{"id":107163,"date":"2021-02-16T12:37:59","date_gmt":"2021-02-16T12:37:59","guid":{"rendered":"https:\/\/fin2me.com\/?p=107163"},"modified":"2021-02-16T12:37:59","modified_gmt":"2021-02-16T12:37:59","slug":"cvs-health-q4-results-top-estimates","status":"publish","type":"post","link":"https:\/\/fin2me.com\/business\/cvs-health-q4-results-top-estimates\/","title":{"rendered":"CVS Health Q4 Results Top Estimates"},"content":{"rendered":"
CVS Health Corp. (CVS) reported on Wednesday a profit for the fourth quarter that declined 44 percent from last year, hurt by higher benefit costs and expenses, despite a 4 percent revenue growth. Both adjusted earnings per share from continuing operations and quarterly revenues topped analysts’ expectations. The company also initiated earnings and adjusted earnings guidance for the full-year 2021.<\/p>\n
For the fourth quarter, the company reported net income attributable to the company of $973 million or $0.74 per share, sharply lower than $1.75 billion or $1.33 per share in the prior-year quarter.<\/p>\n
Excluding items, adjusted income from continuing operations attributable to the company for the quarter was $1.71 billion or $1.30 per share, compared to $2.27 billion or $1.73 per share in the year-ago quarter.<\/p>\n
On average, 23 analysts polled by Thomson Reuters expected the company to report earnings of $1.24 per share for the quarter. Analysts’ estimates typically exclude special items.<\/p>\n
Total revenues for the quarter grew 4.0 percent to $69.55 billion from $66.89 billion in the same quarter last year, primarily driven by growth in the Health Care Benefits and Retail\/LTC segments. Analysts expected revenues of $68.75 billion for the quarter.<\/p>\n
The Pharmacy Services segment revenues declined 1.9 percent to $36.36 billion from $37.07 billion, while Retail\/LTC segment revenues grew 6.6 percent to $24.06 billion from $22.58 billion and Health Care Benefits segment revenues increased 11.4 percent to $19.10 billion from $17.15 billion from last year.<\/p>\n
Looking ahead for 2021, the company expects earnings from continuing operations in range of $6.06 to $6.22 per share, and adjusted earnings in a range of $7.39 to $7.55 per share. Analysts expect annual earnings of $7.54 per share. <\/p>\n
CVS Health is in the process of administering COVID-19 vaccinations to eligible people after inking a public-private Pharmacy Partnership with the U.S. government to provide and administer COVID-19 vaccines to protect vulnerable American residents of long-term care facilities (LTCF) nationwide with no out-of-pocket costs. <\/p>\n